377 related articles for article (PubMed ID: 18773529)
1. Marek's disease vaccines: a solution for today but a worry for tomorrow?
Gimeno IM
Vaccine; 2008 Jul; 26 Suppl 3():C31-41. PubMed ID: 18773529
[TBL] [Abstract][Full Text] [Related]
2. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.
Buscaglia C; Nervi P; Risso M
Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986
[TBL] [Abstract][Full Text] [Related]
3. Host genetic resistance to Marek's disease sustains protective efficacy of herpesvirus of turkey in both experimental and commercial lines of chickens.
Chang S; Xie Q; Dunn JR; Ernst CW; Song J; Zhang H
Vaccine; 2014 Apr; 32(16):1820-7. PubMed ID: 24530405
[TBL] [Abstract][Full Text] [Related]
4. Marek's disease vaccines: Current status, and strategies for improvement and development of vector vaccines.
Reddy SM; Izumiya Y; Lupiani B
Vet Microbiol; 2017 Jul; 206():113-120. PubMed ID: 28038868
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.
Li K; Liu Y; Liu C; Gao L; Zhang Y; Cui H; Gao Y; Qi X; Zhong L; Wang X
Sci Rep; 2016 Dec; 6():39263. PubMed ID: 27982090
[TBL] [Abstract][Full Text] [Related]
6. History of the First-Generation Marek's Disease Vaccines: The Science and Little-Known Facts.
Schat KA
Avian Dis; 2016 Dec; 60(4):715-724. PubMed ID: 27902902
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of various Marek's disease vaccines protocols for prevention of Marek's disease virus-induced immunosuppression.
Faiz NM; Cortes AL; Guy JS; Fogle JE; Gimeno IM
Vaccine; 2016 Jul; 34(35):4180-4187. PubMed ID: 27371103
[TBL] [Abstract][Full Text] [Related]
8. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
Baigent SJ; Smith LP; Nair VK; Currie RJ
Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084
[TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of a recombinant bacterial artificial chromosome clone of a very virulent Marek's disease virus containing a reticuloendotheliosis virus long terminal repeat.
Mays JK; Black-Pyrkosz A; Spatz S; Fadly AM; Dunn JR
Avian Pathol; 2016 Dec; 45(6):657-666. PubMed ID: 27258614
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of cell-associated vaccines against Marek's disease virus grown in QT35 cells or JBJ-1 cells.
Geerligs H; Spijkers I; Rodenberg J
Avian Dis; 2013 Jun; 57(2 Suppl):448-53. PubMed ID: 23901760
[TBL] [Abstract][Full Text] [Related]
12. A deletion in the glycoprotein L (gL) gene of U.S. Marek's disease virus (MDV) field strains is insufficient to confer increased pathogenicity to the bacterial artificial chromosome (BAC)-based strain, RB-1B.
Shaikh SA; Katneni UK; Dong H; Gaddamanugu S; Tavlarides-Hontz P; Jarosinski KW; Osterrieder N; Parcells MS
Avian Dis; 2013 Jun; 57(2 Suppl):509-18. PubMed ID: 23901769
[TBL] [Abstract][Full Text] [Related]
13. Use of Marek's disease vaccines: could they be driving the virus to increasing virulence?
Davison F; Nair V
Expert Rev Vaccines; 2005 Feb; 4(1):77-88. PubMed ID: 15757475
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of mass vaccination on Marek's disease virus (MDV) outbreaks and detection within a broiler barn: a modeling study.
Atkins KE; Read AF; Walkden-Brown SW; Savill NJ; Woolhouse ME
Epidemics; 2013 Dec; 5(4):208-17. PubMed ID: 24267877
[TBL] [Abstract][Full Text] [Related]
15. Protection provided by Rispens CVI988 vaccine against Marek's disease virus isolates of different pathotypes and early prediction of vaccine take and MD outcome.
Ralapanawe S; Walkden-Brown SW; Renz KG; Islam AF
Avian Pathol; 2016; 45(1):26-37. PubMed ID: 26503904
[TBL] [Abstract][Full Text] [Related]
16. Evolution of Marek's disease -- a paradigm for incessant race between the pathogen and the host.
Nair V
Vet J; 2005 Sep; 170(2):175-83. PubMed ID: 16129338
[TBL] [Abstract][Full Text] [Related]
17. Circulating hypervirulent Marek's disease viruses in vaccinated chicken flocks in Taiwan by genetic analysis of meq oncogene.
Cheng MC; Lai GH; Tsai YL; Lien YY
PLoS One; 2024; 19(5):e0303371. PubMed ID: 38728352
[TBL] [Abstract][Full Text] [Related]
18. Recombinant fowlpox virus vaccines against Australian virulent Marek's disease virus: gene sequence analysis and comparison of vaccine efficacy in specific pathogen free and production chickens.
Heine HG; Foord AJ; Young PL; Hooper PT; Lehrbach PR; Boyle DB
Virus Res; 1997 Jul; 50(1):23-33. PubMed ID: 9255932
[TBL] [Abstract][Full Text] [Related]
19. A comparative evaluation of the protective efficacy of rMd5deltaMeq and CVI988/ Rispens against a vv+ strain of Marek's disease virus infection in a series of recombinant congenic strains of White Leghorn chickens.
Chang S; Ding Z; Dunn JR; Lee LF; Heidari M; Song J; Ernst CW; Zhang H
Avian Dis; 2011 Sep; 55(3):384-90. PubMed ID: 22017035
[TBL] [Abstract][Full Text] [Related]
20. Identification of Marek's disease virus genes associated with virulence of US strains.
Dunn JR; Black Pyrkosz A; Steep A; Cheng HH
J Gen Virol; 2019 Jul; 100(7):1132-1139. PubMed ID: 31184569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
